Speaker Biographies 2017

Day One: TUESDAY 23rd MAY

Opening:

CAROLYN GULLERY General Manager, Planning, Funding and Decision Support, CDHB Carolyn’s nearly 30 years’ experience in health started with her role as Pharmaceutical Division Manager for Abbott Laboratories (NZ). Since joining the Southern Regional Health Authority in 1993 Carolyn has had a variety of strategic roles including membership on the Pathology and Laboratory Round Table and a role on the local Laboratory Service Level Alliance. Carolyn is currently the General Manager of Planning, Funding and Decision Support for Canterbury and West Coast DHBs. She is on the Alliance Leadership Team for the Canterbury Clinical Network and the Strategic Planning and Integration Team for the South Island Alliance and chairs the GMs Planning and Funding Network. Carolyn was instrumental in the development of the alliance policy and framework for the NZ health setting.

Session One: Strengthening Clinical Relationships

Johanna McCord Innovation Director, Via innovations Johanna has a background in law, science and entrepreneurship. She provides innovators with intellectual property protection, structuring and commercialisation advice, and commercial and industry knowledge.

DR LOGAN WALKER Senior Research Fellow, Mackenzie Cancer Research Group, University of Otago Logan had completed a PhD in breast cancer genetics from the University of Otago before moving to Brisbane to undertake a four year postdoctoral position at the QIMR Berghofer Medical Research Institute. After returning to University of Otago in 2011, Logan was awarded the Sir Charles Hercus Health Research Fellowship from the Health Research Council, and in 2015 was awarded a Rutherford Discovery Fellowship from the Royal Society of New Zealand. Logan currently leads a cancer genomics program aiming to align healthcare initiatives with the rapidly evolving field of genomic medicine. A key component of his research is developing methods for evaluating the clinical significance of genetic changes and assessing their utility in a diagnostic setting. Logan is the principal investigator of the New Zealand Familial Breast Cancer Study and is a member of the world-leading consortia, ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) and CIMBA (Consortium of Investigators of Modifiers of BRCA1/2).

Session Two: Leadership and Innovation

PIET BEUKMAN Associate Professor, University of Canterbury Piet is currently Director of the Master of Engineering Management programme and a former director of the Master of Business Administration (MBA) at the University of Canterbury. Piet mentors CEOs, consults with businesses and he also delivers training workshops.

Piet has presented numerous short courses and custom in-house workshops for local and international organisations including technology companies, district and city councils, electricity companies, infrastructure companies, government departments, and sports organisations.

Piet has developed a unique training style that combines underlying theory, practical examples and case studies into an integrated programme. He believes that learning should take place in a relaxed and friendly environment and that underlying principles should be taught first, before specifics, applications or tools are addressed. Participants therefore gain a thinking framework that can be readily remembered and applied over a wide spectrum in the workplace.

CRAIG RENSHAW Human Capital Manager, Deloitte Craig is a Senior Consultant in Deloitte's People & Workforce Analytics practise. Craig is passionate about using HR data to help organisations make better decisions around talent, workforce planning and organisation design. Craig is also experienced in using HR technologies as an enabler for this work with recent projects including a large Workday implementation and an organisation review using OrgVue. GEORGIA VAN TONGEREN Human Capital Analyst, Deloitte Georgia is an Analyst in Deloitte’s Human Capital Consulting practice. She is a Christchurch local and holds a Bachelor and Master of Commerce from the University of Canterbury. Georgia joined Deloitte after working in Trade Marketing at Fairfax Media, involved with a range of projects including bringing the Night Noodle Markets to the city. Since joining Deloitte, Georgia has been engaged in work with a variety of private and public sector clients. She is currently working with a team at CDHB on the People Lifecycle Project to transform HR.

MICHAEL FRAMPTON General Manager, People and Capability, Canterbury DHB and West Coast DHB Michael leads the People and Capability team and, with his leadership group, shares accountability for repositioning a traditional Human Resources department into a contemporary People and Capability function that can truly enable and support the achievement of the vision and goals for Our Health Systems. Michael previously held the position of Programme Director for the West Coast DHB. In this role, he worked with the Executive Teams of the West Coast and Canterbury to lead and drive the programme of change to transform West Coast health services. His experience includes more than twelve years in senior leadership roles in the corporate and public sectors both within New Zealand and abroad. Before beginning in health, Michael succeeded with a range of leadership and capability building challenges in industries including financial services, energy, manufacturing and the public sector, with work experience in Asia and the Pacific, North America and New Zealand. Michael has a Bachelor of Arts in Political Science from the University of Canterbury, and an MBA from Henley Business School in the UK. His key competencies include executive, change and project leadership; broad strategy development and execution; corporate and government affairs; regulatory affairs; and communications management and media relations. He is passionate about leadership and the opportunity, and power, of distributed leadership in large, complex organisations.

Session Three: Emerging use of e-Technologies

PETER DOOLEY Charge MRI Technologist, Canterbury DHB Peter Dooley’s strategy is to use Virtual reality in a cost-effective, safe and engaging way to inform and build trust in young patients. High levels of sedation for many procedures are used in the Canterbury Health System driven in part by increasing levels of mental health issues and anxiety. By putting children in simulated reality, it would give them back some control of the experience and provide a means of understanding what would be happening to them. To experience, albeit in an imaginary way, the procedure would allow children to stay in better control of their emotions and negate the need for sedation.

HEATHER PHILLIPS Digital Communicator and Managing Director, Phillips & Phillips Heather is a digital PR and communications agency that works to develop brand reputations. Prior to her career in communications she gained her Bachelor of Science in Biotechnology, and then began a 6 year campaign in educating the nation on the science behind one of New Zealand’s most controversial pest control tools. She works with clients across the country in the science, IT, finance, Iwi and policy development sectors. When it comes to new ideas and innovation Heather is passionate about making sure others hear their story.’

DAVID PRICE Director of Patient Experience, Waitemata DHB David Price was appointed Director of Patient Experience in April 2016. David trained as an Occupational Therapist in Melbourne, Australia and has since undertaken a Master of Business Administration (with Dean's Commendation) from La Trobe University, Melbourne. David champions co-design methodology in all quality improvement and service redesign, ensuring patients and family / whānau are at the centre of solution generation with service planning and strategy.

David comes to his current role following over five years at Northern Health in Melbourne where he held roles including Director of Patient Experience and Consumer Participation, Low Risk Ethics Committee Chair, Acting Director of Allied Health Learning and Research and Occupational Therapy Clinical Lead.

Session Four: Pathology Beyond the Laboratory – the emergence of Point of Care Testing

Dr TOM MULHOLLAND Emergency SMO, Auckland City Hospital Dr Tom Mulholland is an Emergency Department Doctor at Auckland City

Hospital who has hit the road in a Chevy V8 Ambulance over the past few years. He has been taking the lab on the road testing for HBAIC and Lipids to

remote communities, workplaces and supermarket checkouts.

Dr Tom began his working carer while at school and University working as a

Labtech for the National Health Institute. He obtained a 1st Class Honours degree in Molecular Genetics from the University of Canterbury before

attending Medical School at Otago.

Dr Tom was founding Chairman of LABCare a JV between the Taranaki District

Health Board and local provider Medlab. He has written 2 internationally best-selling books, hosted his own National Radio and TV shows and is a weekly

wellbeing contributor to the Sunday Star Times.

Dr Tom is in demand as an international speaker and has worked for

companies like Google, Microsoft, Hilton and hundreds of others training them in Healthy Thinking and How to stay out of the Emergency Department.

DR STEPHEN BRAYE Network Director of Pathology North Dr Stephen Bray graduated from the University of NSW in 1976 with the degree of MBBS, BSc (Med). He was admitted as a Fellow of the Royal College of Pathologists (RPCA) in 1985 and as a Fellow of the Royal College of Pathologists of Australasia (FRCPA) in 1986. Dr Braye has worked as a Staff Specialist in Anatomical Pathology in public practice in Australia since 1987 at Prince of Wales Hospital, ICPMR and Hunter Area Pathology Service (HAPS). During his time at HAPS, Stephen has had a passionate interest in Cytology, supporting and developing the department. Stephen has a special interest in breast and thyroid cytology in particular, and is the accredited pathologist for Breast Screen in Newcastle. Dr Braye has been a Senior Staff Specialist, Anatomical Pathology at HAPS since 1990 with periods as Director of Anatomical Pathology. In September 2009, with the formation of Pathology North, Dr Braye was appointed to the position of Assistant Director Pathology North – Hunter until October 2011 when he was appointed Network Director, Pathology North.

Dinner Speaker – the patient view

Anaru Moke Andrew (Anaru) Tuhira Moke was born in Tekuiti and is from a family of 14 and has spent the last 26 years living in Wellington. Anaru has 11 children and 11 mokos. Cancer and diabetes runs in his family and 4 years ago he was diagnosed with multiple myeloma and underwent chemo treatment followed by a stem cell transplant in Wellington. Last year Anaru met Dr Tom who is helping him understand his diabetes and helping him recover.

Speaker Biographies 2017

Day Two: Wednesday 24th MAY

Opening:

KIRSTEN BEYNON General Manager, Canterbury Health Laboratories & West Coast DHB Laboratory Kirsten Beynon has been employed by Canterbury Health Laboratories since 1996, where she held various scientific and managerial positions within the Virology Department. In 2005 Kirsten was appointed to the Operations Manager role at Canterbury Health Laboratories. Kirsten has most recently being appointed to the role of General Manager of Canterbury Health and West Coast Laboratories. Kirsten was elected to be a representative of the Clinical Board from 2012 to 2015. Kirsten holds a Master of Medical Laboratory Science from Massey University. Kirsten is an experienced people leader with proven operational, project management and leadership skills within the health sector. She is very committed to achieving successful outcomes and providing a high quality service to benefit the patient and the health system.

Session Five: Business Intelligence

DAVID CARTER Director, Stratos David has nearly 20 years of experience in the software development field working for a variety of companies locally and abroad.

He is one of the founding partners of Stratos Technology Partners and chair of the Canterbury Tech Cluster.

MARTIN THAN Emergency Medicine Specialist, CDHB Martin is director of research at Christchurch Emergency Department and has a

specific interest in evidence-based healthcare and the safe rapid translation of

research findings into clinical practice. His work focuses on cardiac biomarkers and

acute coronary syndrome with approximately 100 papers in this field since 2011.

Martin has now led two randomised controlled trials on the benefits of using accelerated decision making pathways for patients being assessed for possible ACS, and led the implementation of rapid chest pain assessment pathways into every hospital throughout New Zealand.

DR SANDIP GUPTA Full Professor and Deputy Head of Pathology and Molecular Medicine, Queen’s University and Kingston Health Sciences Centre, Canada Sandip has more than 25 years of diverse experience as a laboratory physician leader within the full spectrum of primary, secondary, and tertiary care hospital laboratories. Sandip is recognised for his medical expertise in regional laboratory systems design and innovation, and in laboratory quality improvement. His laboratory at Kingston General Hospital was an early adopter of Lean Process Excellence and quality benchmarking. Sandip’s current interests focus upon demonstrating the value proposition of diagnostic laboratory testing to improved healthcare outcomes for patients, and the value that laboratorians create through external multidisciplinary collaborations in pre-analytical and post-analytical laboratory operations.

Session Six: Turning Information into Action

MICHAEL REAKES CEO, Pacific Knowledge Systems Michael is the Chief Executive Officer of Pacific Knowledge Systems (PKS). Having previously held the position of Chief Information Officer since 2015, Michael was appointed CEO in 2016 and is responsible for the delivery of PK’s company strategy with a keen focus on the continuous improvement of PKS’s clinical decision support (CDS) product and service offerings. In his time with PKS Michael has delivered a range of initiatives that have significantly enhanced the usability of the CDS product and accelerated the adoption of CDS globally. Prior to joining PKS, Michael held a variety of technical leadership roles in Australia and Asia Pacific, working on large scale transformation programs with IBM, Commonwealth Bank of Australia, Department of Immigration, News Limited and Deutsche Bank. Michael holds a degree in Systems Engineering and Computer Science from the Australian National University (Canberra, Australia).

Professor STEVE CHAMBERS University of Otago Professor Steve Chamber's research interests relate to diagnostics in respiratory infections, the treatment of infectious diseases and intermediary metabolism with particular emphasis on the relationship between bacterial and human metabolism. He is interested in the effective delivery of treatment for infectious disease that minimises harm to the patient depends on rapid, accurate diagnosis of the infecting organism. Clinical studies undertaken by Professor Chambers and his team have confirmed the limitations of current methods such as culture and PCR, particularly in children, which depend on the collection of sputum and other specimens. This lead the concept of diagnostic breath testing, which can be performed on readily available samples that can be easily repeated, to follow microbial metabolism.

Session Six (continued): Turning Information into Action

MARTIN THAN Emergency Medicine Specialist, CDHB Martin is director of research at Christchurch Emergency Department and has a

specific interest in evidence-based healthcare and the safe rapid translation of

research findings into clinical practice. His work focuses on cardiac biomarkers and

acute coronary syndrome with approximately 100 papers in this field since 2011.

Martin has now led two randomised controlled trials on the benefits of using accelerated decision making pathways for patients being assessed for possible ACS, and led the implementation of rapid chest pain assessment pathways into every hospital throughout New Zealand.

Session Seven: Back by Popular Demand – CHL Science/Case Studies

Grant Moore Toxicology Section Head, Canterbury Health Laboratories Grant has worked in the Toxicology area at Canterbury Health Labs for over 30 years. In that time there have been significant advances in the methodologies employed for drug screening and therapeutic drug monitoring. He has seen the use of thin layer chromatographic drug screening replaced with Liquid Chromatography-Mass Spectrometry (LCMS) and the subsequent marked improvements in sensitivity and service. He has overseen the advent of the Workplace Drug Screening service and its subsequent expansion within the Canterbury Health Laboratories organisation. He is frequently asked to audit Workplace Drug Screening labs across Australia and is currently the Chair of the Toxicology Working Party for the RCPA Quality Assurance Programme.

Elly Barnes POCT Co-ordinator, Canterbury Health Laboratories Elly has over 15 years’ experience as a medical laboratory scientist in the Biochemistry department at Canterbury Health Laboratories. Throughout that time she has assisted in point of care testing before taking on the role of Point of Care Testing coordinator a year ago. Since then, Elly has been involved in the assessment of new generation point of care equipment, as well as helping to facilitate a nationwide pregnancy test evaluation in association with the New Zealand Point of Care Testing Advisory Group (NZPOCTAG), of which she is an integral member.

Assoc Prof Lance Jennings Clinical Virologist Lance is Clinical Virologist to the Canterbury District Health Board, Director of New Zealand's World Health Organization (WHO) National Measles Laboratory, Clinical Associate Professor in the Pathology Department, University of Otago, New Zealand, Fellow of the Royal College of Pathologists, London and a Founding Fellow of the Science Faculty, Royal Australasian College of Pathologists. His principal research interests include the epidemiology, diagnosis, prevention and treatment of influenza and other respiratory viral infections. Lance has been instrumental in the development of influenza control strategies for New Zealand, including the introduction of free influenza vaccine, establishment of influenza awareness education (NISG) and pandemic planning. He is the current chair of the Asia Pacific Alliance for the Control of Influenza (APACI) and has held WHO short-term consultancies on measles and influenza in Asia and Europe. Dr Jennings has also been a member of WHO/Western Pacific Region Office (WPRO) Avian Influenza Outbreak Response (2004) and Expert Influenza (2005) teams in Asia.

Canterbury Health Laboratories is grateful for support from: